The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. TGOD.TO Peers
See (TGOD.TO) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TGOD.TO | $0.17 | N/A | N/A | -0.74 | -$0.23 | N/A |
| CURA.CN | $5.22 | +9.21% | 4.07B | -6.07 | -$0.86 | N/A |
| BHC.TO | $6.39 | -1.84% | 2.36B | -37.59 | -$0.17 | N/A |
| VRNO.CN | $6.32 | +6.76% | 2.17B | -5.40 | -$1.17 | N/A |
| GTII.CN | $7.72 | +0.26% | 1.83B | 26.62 | $0.29 | N/A |
| TRUL.CN | $6.29 | -0.79% | 1.22B | -5.72 | -$1.10 | N/A |
| CRON.TO | $2.88 | +1.77% | 1.11B | 15.16 | $0.19 | N/A |
| CURA.TO | $1.23 | +1.65% | 920.68M | -2.67 | -$0.46 | N/A |
| TER.CN | $2.38 | -0.42% | 804.79M | -1.33 | -$1.79 | N/A |
| DHT-UN.TO | $12.50 | +0.48% | 703.89M | -156.25 | -$0.08 | +7.74% |
Stock Comparison
TGOD.TO vs CURA.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CURA.CN has a market cap of 4.07B. Regarding current trading prices, TGOD.TO is priced at $0.17, while CURA.CN trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CURA.CN's ROE of -0.14%. Regarding short-term risk, TGOD.TO is more volatile compared to CURA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs BHC.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, BHC.TO has a market cap of 2.36B. Regarding current trading prices, TGOD.TO is priced at $0.17, while BHC.TO trades at $6.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas BHC.TO's P/E ratio is -37.59. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to BHC.TO's ROE of +0.03%. Regarding short-term risk, TGOD.TO is more volatile compared to BHC.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs VRNO.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, VRNO.CN has a market cap of 2.17B. Regarding current trading prices, TGOD.TO is priced at $0.17, while VRNO.CN trades at $6.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas VRNO.CN's P/E ratio is -5.40. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to VRNO.CN's ROE of -0.10%. Regarding short-term risk, TGOD.TO is more volatile compared to VRNO.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs GTII.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, GTII.CN has a market cap of 1.83B. Regarding current trading prices, TGOD.TO is priced at $0.17, while GTII.CN trades at $7.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas GTII.CN's P/E ratio is 26.62. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to GTII.CN's ROE of +0.04%. Regarding short-term risk, TGOD.TO is more volatile compared to GTII.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs TRUL.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, TRUL.CN has a market cap of 1.22B. Regarding current trading prices, TGOD.TO is priced at $0.17, while TRUL.CN trades at $6.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas TRUL.CN's P/E ratio is -5.72. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to TRUL.CN's ROE of -0.12%. Regarding short-term risk, TGOD.TO is more volatile compared to TRUL.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs CRON.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CRON.TO has a market cap of 1.11B. Regarding current trading prices, TGOD.TO is priced at $0.17, while CRON.TO trades at $2.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CRON.TO's P/E ratio is 15.16. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CRON.TO's ROE of +0.04%. Regarding short-term risk, TGOD.TO is more volatile compared to CRON.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs CURA.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CURA.TO has a market cap of 920.68M. Regarding current trading prices, TGOD.TO is priced at $0.17, while CURA.TO trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CURA.TO's P/E ratio is -2.67. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CURA.TO's ROE of -0.22%. Regarding short-term risk, TGOD.TO is more volatile compared to CURA.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs TER.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, TER.CN has a market cap of 804.79M. Regarding current trading prices, TGOD.TO is priced at $0.17, while TER.CN trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas TER.CN's P/E ratio is -1.33. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to TER.CN's ROE of -0.37%. Regarding short-term risk, TGOD.TO is more volatile compared to TER.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs DHT-UN.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, DHT-UN.TO has a market cap of 703.89M. Regarding current trading prices, TGOD.TO is priced at $0.17, while DHT-UN.TO trades at $12.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas DHT-UN.TO's P/E ratio is -156.25. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to DHT-UN.TO's ROE of -0.01%. Regarding short-term risk, TGOD.TO is more volatile compared to DHT-UN.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs TLRY.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, TLRY.TO has a market cap of 615.60M. Regarding current trading prices, TGOD.TO is priced at $0.17, while TLRY.TO trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas TLRY.TO's P/E ratio is -0.40. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to TLRY.TO's ROE of -0.29%. Regarding short-term risk, TGOD.TO is more volatile compared to TLRY.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs GUD.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, GUD.TO has a market cap of 574.81M. Regarding current trading prices, TGOD.TO is priced at $0.17, while GUD.TO trades at $5.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas GUD.TO's P/E ratio is 57.80. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to GUD.TO's ROE of +0.01%. Regarding short-term risk, TGOD.TO is more volatile compared to GUD.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs DHT-U.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, DHT-U.TO has a market cap of 464.56M. Regarding current trading prices, TGOD.TO is priced at $0.17, while DHT-U.TO trades at $8.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas DHT-U.TO's P/E ratio is -137.50. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to DHT-U.TO's ROE of -0.01%. Regarding short-term risk, TGOD.TO is more volatile compared to DHT-U.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs ACB.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, ACB.TO has a market cap of 386.38M. Regarding current trading prices, TGOD.TO is priced at $0.17, while ACB.TO trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas ACB.TO's P/E ratio is 26.07. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to ACB.TO's ROE of -0.06%. Regarding short-term risk, TGOD.TO is more volatile compared to ACB.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs WEED.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, WEED.TO has a market cap of 365.70M. Regarding current trading prices, TGOD.TO is priced at $0.17, while WEED.TO trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas WEED.TO's P/E ratio is -0.39. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to WEED.TO's ROE of -0.88%. Regarding short-term risk, TGOD.TO is more volatile compared to WEED.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs VRNO.NE Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, VRNO.NE has a market cap of 363.32M. Regarding current trading prices, TGOD.TO is priced at $0.17, while VRNO.NE trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas VRNO.NE's P/E ratio is -0.72. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to VRNO.NE's ROE of -0.27%. Regarding short-term risk, TGOD.TO is more volatile compared to VRNO.NE. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs CL.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CL.CN has a market cap of 330.47M. Regarding current trading prices, TGOD.TO is priced at $0.17, while CL.CN trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CL.CN's P/E ratio is -3.16. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CL.CN's ROE of -0.16%. Regarding short-term risk, TGOD.TO is more volatile compared to CL.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs CPH.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CPH.TO has a market cap of 319.41M. Regarding current trading prices, TGOD.TO is priced at $0.17, while CPH.TO trades at $12.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CPH.TO's P/E ratio is 24.94. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CPH.TO's ROE of +0.12%. Regarding short-term risk, TGOD.TO is more volatile compared to CPH.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs CCHW.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CCHW.CN has a market cap of 228.66M. Regarding current trading prices, TGOD.TO is priced at $0.17, while CCHW.CN trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CCHW.CN's P/E ratio is -0.41. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CCHW.CN's ROE of -1.08%. Regarding short-term risk, TGOD.TO is more volatile compared to CCHW.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs OGI.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, OGI.TO has a market cap of 213.37M. Regarding current trading prices, TGOD.TO is priced at $0.17, while OGI.TO trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas OGI.TO's P/E ratio is -3.45. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to OGI.TO's ROE of -0.18%. Regarding short-term risk, TGOD.TO is more volatile compared to OGI.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs TH.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, TH.TO has a market cap of 161.39M. Regarding current trading prices, TGOD.TO is priced at $0.17, while TH.TO trades at $3.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas TH.TO's P/E ratio is -35.10. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to TH.TO's ROE of +0.16%. Regarding short-term risk, TGOD.TO is more volatile compared to TH.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs TSND.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, TSND.TO has a market cap of 158.22M. Regarding current trading prices, TGOD.TO is priced at $0.17, while TSND.TO trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas TSND.TO's P/E ratio is 54.00. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to TSND.TO's ROE of -0.37%. Regarding short-term risk, TGOD.TO is more volatile compared to TSND.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs HLS.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, HLS.TO has a market cap of 152.92M. Regarding current trading prices, TGOD.TO is priced at $0.17, while HLS.TO trades at $4.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas HLS.TO's P/E ratio is -6.09. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to HLS.TO's ROE of -0.24%. Regarding short-term risk, TGOD.TO is more volatile compared to HLS.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs BHSC.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, BHSC.CN has a market cap of 137.76M. Regarding current trading prices, TGOD.TO is priced at $0.17, while BHSC.CN trades at $7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas BHSC.CN's P/E ratio is -4.37. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to BHSC.CN's ROE of +9.56%. Regarding short-term risk, TGOD.TO is more volatile compared to BHSC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs GRIN.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, GRIN.CN has a market cap of 133.84M. Regarding current trading prices, TGOD.TO is priced at $0.17, while GRIN.CN trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas GRIN.CN's P/E ratio is -7.71. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to GRIN.CN's ROE of -0.89%. Regarding short-term risk, TGOD.TO is more volatile compared to GRIN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs CRDL.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CRDL.TO has a market cap of 128.07M. Regarding current trading prices, TGOD.TO is priced at $0.17, while CRDL.TO trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CRDL.TO's P/E ratio is -3.04. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CRDL.TO's ROE of -2.08%. Regarding short-term risk, TGOD.TO is more volatile compared to CRDL.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs PLTH.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, PLTH.CN has a market cap of 120.35M. Regarding current trading prices, TGOD.TO is priced at $0.17, while PLTH.CN trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas PLTH.CN's P/E ratio is -1.68. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to PLTH.CN's ROE of -0.36%. Regarding short-term risk, TGOD.TO is more volatile compared to PLTH.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs XLY.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, XLY.TO has a market cap of 118.17M. Regarding current trading prices, TGOD.TO is priced at $0.17, while XLY.TO trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas XLY.TO's P/E ratio is -9.00. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to XLY.TO's ROE of -0.15%. Regarding short-term risk, TGOD.TO is more volatile compared to XLY.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs JUSH.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, JUSH.CN has a market cap of 92.45M. Regarding current trading prices, TGOD.TO is priced at $0.17, while JUSH.CN trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas JUSH.CN's P/E ratio is -1.34. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to JUSH.CN's ROE of +1.45%. Regarding short-term risk, TGOD.TO is more volatile compared to JUSH.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs GDNS.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, GDNS.CN has a market cap of 90.99M. Regarding current trading prices, TGOD.TO is priced at $0.17, while GDNS.CN trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas GDNS.CN's P/E ratio is -2.74. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to GDNS.CN's ROE of +1.61%. Regarding short-term risk, TGOD.TO is more volatile compared to GDNS.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs MDP.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, MDP.TO has a market cap of 80.65M. Regarding current trading prices, TGOD.TO is priced at $0.17, while MDP.TO trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas MDP.TO's P/E ratio is 11.90. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to MDP.TO's ROE of +0.11%. Regarding short-term risk, TGOD.TO is more volatile compared to MDP.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs TGOD.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, TGOD.CN has a market cap of 62.18M. Regarding current trading prices, TGOD.TO is priced at $0.17, while TGOD.CN trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas TGOD.CN's P/E ratio is -3.28. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to TGOD.CN's ROE of -0.90%. Regarding short-term risk, TGOD.TO is more volatile compared to TGOD.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs BNXT.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, BNXT.CN has a market cap of 57.84M. Regarding current trading prices, TGOD.TO is priced at $0.17, while BNXT.CN trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas BNXT.CN's P/E ratio is -7.29. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to BNXT.CN's ROE of +1.04%. Regarding short-term risk, TGOD.TO is more volatile compared to BNXT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs STEM.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, STEM.CN has a market cap of 53.62M. Regarding current trading prices, TGOD.TO is priced at $0.17, while STEM.CN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas STEM.CN's P/E ratio is -0.11. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to STEM.CN's ROE of -2.75%. Regarding short-term risk, TGOD.TO is more volatile compared to STEM.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs INNO.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, INNO.CN has a market cap of 47.87M. Regarding current trading prices, TGOD.TO is priced at $0.17, while INNO.CN trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas INNO.CN's P/E ratio is -16.50. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to INNO.CN's ROE of -0.38%. Regarding short-term risk, TGOD.TO is more volatile compared to INNO.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs MRMD.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, MRMD.CN has a market cap of 46.71M. Regarding current trading prices, TGOD.TO is priced at $0.17, while MRMD.CN trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas MRMD.CN's P/E ratio is -3.00. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to MRMD.CN's ROE of -0.18%. Regarding short-term risk, TGOD.TO is more volatile compared to MRMD.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs AYR-A.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, AYR-A.CN has a market cap of 42.04M. Regarding current trading prices, TGOD.TO is priced at $0.17, while AYR-A.CN trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas AYR-A.CN's P/E ratio is -0.08. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to AYR-A.CN's ROE of -0.68%. Regarding short-term risk, TGOD.TO is more volatile compared to AYR-A.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs LABS.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, LABS.TO has a market cap of 41.51M. Regarding current trading prices, TGOD.TO is priced at $0.17, while LABS.TO trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas LABS.TO's P/E ratio is -3.33. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to LABS.TO's ROE of -0.23%. Regarding short-term risk, TGOD.TO is more volatile compared to LABS.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs HEXO.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, HEXO.TO has a market cap of 38.72M. Regarding current trading prices, TGOD.TO is priced at $0.17, while HEXO.TO trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas HEXO.TO's P/E ratio is -0.26. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to HEXO.TO's ROE of -2.06%. Regarding short-term risk, TGOD.TO is more volatile compared to HEXO.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs CBST.NE Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CBST.NE has a market cap of 38.38M. Regarding current trading prices, TGOD.TO is priced at $0.17, while CBST.NE trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CBST.NE's P/E ratio is -0.26. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CBST.NE's ROE of -6.64%. Regarding short-term risk, TGOD.TO is more volatile compared to CBST.NE. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs CHM.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CHM.CN has a market cap of 37.21M. Regarding current trading prices, TGOD.TO is priced at $0.17, while CHM.CN trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CHM.CN's P/E ratio is -5.00. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CHM.CN's ROE of +0.15%. Regarding short-term risk, TGOD.TO is more volatile compared to CHM.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs IAN.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, IAN.CN has a market cap of 33.73M. Regarding current trading prices, TGOD.TO is priced at $0.17, while IAN.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas IAN.CN's P/E ratio is -0.50. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to IAN.CN's ROE of +0.10%. Regarding short-term risk, TGOD.TO is more volatile compared to IAN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs EPIC.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, EPIC.CN has a market cap of 29.43M. Regarding current trading prices, TGOD.TO is priced at $0.17, while EPIC.CN trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas EPIC.CN's P/E ratio is 12.50. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to EPIC.CN's ROE of +0.06%. Regarding short-term risk, TGOD.TO is more volatile compared to EPIC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs VEXT.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, VEXT.CN has a market cap of 28.60M. Regarding current trading prices, TGOD.TO is priced at $0.17, while VEXT.CN trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas VEXT.CN's P/E ratio is -1.00. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to VEXT.CN's ROE of -0.27%. Regarding short-term risk, TGOD.TO is more volatile compared to VEXT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs MMEN.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, MMEN.CN has a market cap of 27.66M. Regarding current trading prices, TGOD.TO is priced at $0.17, while MMEN.CN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas MMEN.CN's P/E ratio is -0.13. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to MMEN.CN's ROE of -0.96%. Regarding short-term risk, TGOD.TO and MMEN.CN have similar daily volatility (28.57).
TGOD.TO vs AVCN.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, AVCN.TO has a market cap of 26.85M. Regarding current trading prices, TGOD.TO is priced at $0.17, while AVCN.TO trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas AVCN.TO's P/E ratio is -6.00. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to AVCN.TO's ROE of -3.82%. Regarding short-term risk, TGOD.TO is more volatile compared to AVCN.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs CXXI.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CXXI.CN has a market cap of 25.21M. Regarding current trading prices, TGOD.TO is priced at $0.17, while CXXI.CN trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CXXI.CN's P/E ratio is -5.25. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CXXI.CN's ROE of -0.14%. Regarding short-term risk, TGOD.TO is more volatile compared to CXXI.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs GWAY.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, GWAY.CN has a market cap of 24.99M. Regarding current trading prices, TGOD.TO is priced at $0.17, while GWAY.CN trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas GWAY.CN's P/E ratio is -6.33. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to GWAY.CN's ROE of -0.33%. Regarding short-term risk, TGOD.TO is more volatile compared to GWAY.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs YOUR.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, YOUR.CN has a market cap of 22.94M. Regarding current trading prices, TGOD.TO is priced at $0.17, while YOUR.CN trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas YOUR.CN's P/E ratio is 8.50. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to YOUR.CN's ROE of -1.18%. Regarding short-term risk, TGOD.TO is more volatile compared to YOUR.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs CWEB.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CWEB.TO has a market cap of 22.21M. Regarding current trading prices, TGOD.TO is priced at $0.17, while CWEB.TO trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CWEB.TO's P/E ratio is -0.54. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CWEB.TO's ROE of -0.85%. Regarding short-term risk, TGOD.TO is more volatile compared to CWEB.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs VIN.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, VIN.CN has a market cap of 20.18M. Regarding current trading prices, TGOD.TO is priced at $0.17, while VIN.CN trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas VIN.CN's P/E ratio is -0.67. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to VIN.CN's ROE of -3.88%. Regarding short-term risk, Volatility data is not available for a full comparison. TGOD.TO has daily volatility of 28.57 and VIN.CN has daily volatility of N/A.
TGOD.TO vs RWB.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, RWB.CN has a market cap of 16.46M. Regarding current trading prices, TGOD.TO is priced at $0.17, while RWB.CN trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas RWB.CN's P/E ratio is -0.13. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to RWB.CN's ROE of +0.87%. Regarding short-term risk, TGOD.TO is more volatile compared to RWB.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs MRV.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, MRV.TO has a market cap of 15.37M. Regarding current trading prices, TGOD.TO is priced at $0.17, while MRV.TO trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas MRV.TO's P/E ratio is -19.29. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to MRV.TO's ROE of N/A. Regarding short-term risk, TGOD.TO is more volatile compared to MRV.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs EXM.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, EXM.CN has a market cap of 15.15M. Regarding current trading prices, TGOD.TO is priced at $0.17, while EXM.CN trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas EXM.CN's P/E ratio is -0.91. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to EXM.CN's ROE of -18.63%. Regarding short-term risk, TGOD.TO is more volatile compared to EXM.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs CHAL.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CHAL.CN has a market cap of 14.70M. Regarding current trading prices, TGOD.TO is priced at $0.17, while CHAL.CN trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CHAL.CN's P/E ratio is -2.25. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CHAL.CN's ROE of +0.00%. Regarding short-term risk, TGOD.TO is more volatile compared to CHAL.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs RIV.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, RIV.CN has a market cap of 13.70M. Regarding current trading prices, TGOD.TO is priced at $0.17, while RIV.CN trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas RIV.CN's P/E ratio is -0.21. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to RIV.CN's ROE of -0.92%. Regarding short-term risk, TGOD.TO is more volatile compared to RIV.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs ORI.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, ORI.CN has a market cap of 11.72M. Regarding current trading prices, TGOD.TO is priced at $0.17, while ORI.CN trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas ORI.CN's P/E ratio is -2.11. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to ORI.CN's ROE of +0.51%. Regarding short-term risk, TGOD.TO is more volatile compared to ORI.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs RVV.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, RVV.CN has a market cap of 10.46M. Regarding current trading prices, TGOD.TO is priced at $0.17, while RVV.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas RVV.CN's P/E ratio is -2.50. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to RVV.CN's ROE of -0.70%. Regarding short-term risk, TGOD.TO is more volatile compared to RVV.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs PWR.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, PWR.CN has a market cap of 10.24M. Regarding current trading prices, TGOD.TO is priced at $0.17, while PWR.CN trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas PWR.CN's P/E ratio is -1.17. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to PWR.CN's ROE of -0.79%. Regarding short-term risk, TGOD.TO is more volatile compared to PWR.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs AVNT.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, AVNT.TO has a market cap of 10.17M. Regarding current trading prices, TGOD.TO is priced at $0.17, while AVNT.TO trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas AVNT.TO's P/E ratio is -0.45. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to AVNT.TO's ROE of -0.53%. Regarding short-term risk, TGOD.TO is more volatile compared to AVNT.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs CLC.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CLC.CN has a market cap of 10.14M. Regarding current trading prices, TGOD.TO is priced at $0.17, while CLC.CN trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CLC.CN's P/E ratio is 4.50. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CLC.CN's ROE of +0.11%. Regarding short-term risk, TGOD.TO is more volatile compared to CLC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs TRIP.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, TRIP.CN has a market cap of 10.02M. Regarding current trading prices, TGOD.TO is priced at $0.17, while TRIP.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas TRIP.CN's P/E ratio is -1.25. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to TRIP.CN's ROE of -0.33%. Regarding short-term risk, TGOD.TO is more volatile compared to TRIP.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs CTX.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CTX.TO has a market cap of 9.88M. Regarding current trading prices, TGOD.TO is priced at $0.17, while CTX.TO trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CTX.TO's P/E ratio is -3.71. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CTX.TO's ROE of -0.16%. Regarding short-term risk, TGOD.TO is more volatile compared to CTX.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs CNFA.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CNFA.CN has a market cap of 9.78M. Regarding current trading prices, TGOD.TO is priced at $0.17, while CNFA.CN trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CNFA.CN's P/E ratio is -0.83. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CNFA.CN's ROE of -7.84%. Regarding short-term risk, TGOD.TO is more volatile compared to CNFA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs VIVO.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, VIVO.TO has a market cap of 9.27M. Regarding current trading prices, TGOD.TO is priced at $0.17, while VIVO.TO trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas VIVO.TO's P/E ratio is -0.16. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to VIVO.TO's ROE of -0.78%. Regarding short-term risk, TGOD.TO is more volatile compared to VIVO.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs AUSA.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, AUSA.CN has a market cap of 9.16M. Regarding current trading prices, TGOD.TO is priced at $0.17, while AUSA.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas AUSA.CN's P/E ratio is -0.11. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to AUSA.CN's ROE of +0.00%. Regarding short-term risk, TGOD.TO is more volatile compared to AUSA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs MVMD.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, MVMD.CN has a market cap of 8.81M. Regarding current trading prices, TGOD.TO is priced at $0.17, while MVMD.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas MVMD.CN's P/E ratio is -2.50. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to MVMD.CN's ROE of -0.47%. Regarding short-term risk, TGOD.TO is more volatile compared to MVMD.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs OILS.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, OILS.CN has a market cap of 8.32M. Regarding current trading prices, TGOD.TO is priced at $0.17, while OILS.CN trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas OILS.CN's P/E ratio is -5.00. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to OILS.CN's ROE of -0.22%. Regarding short-term risk, TGOD.TO is more volatile compared to OILS.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs AH.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, AH.TO has a market cap of 8.07M. Regarding current trading prices, TGOD.TO is priced at $0.17, while AH.TO trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas AH.TO's P/E ratio is -0.22. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to AH.TO's ROE of -0.58%. Regarding short-term risk, TGOD.TO and AH.TO have similar daily volatility (28.57).
TGOD.TO vs STHZ.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, STHZ.CN has a market cap of 7.69M. Regarding current trading prices, TGOD.TO is priced at $0.17, while STHZ.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas STHZ.CN's P/E ratio is -0.10. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to STHZ.CN's ROE of +0.10%. Regarding short-term risk, TGOD.TO is more volatile compared to STHZ.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs MOJO.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, MOJO.CN has a market cap of 7.46M. Regarding current trading prices, TGOD.TO is priced at $0.17, while MOJO.CN trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas MOJO.CN's P/E ratio is -5.36. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to MOJO.CN's ROE of -11.49%. Regarding short-term risk, TGOD.TO is more volatile compared to MOJO.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs SPR.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, SPR.CN has a market cap of 7.29M. Regarding current trading prices, TGOD.TO is priced at $0.17, while SPR.CN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas SPR.CN's P/E ratio is -0.40. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to SPR.CN's ROE of +0.00%. Regarding short-term risk, TGOD.TO is more volatile compared to SPR.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs CLSH.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CLSH.CN has a market cap of 7.14M. Regarding current trading prices, TGOD.TO is priced at $0.17, while CLSH.CN trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CLSH.CN's P/E ratio is 4.00. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CLSH.CN's ROE of -0.04%. Regarding short-term risk, TGOD.TO is more volatile compared to CLSH.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs CDVA.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CDVA.CN has a market cap of 7.14M. Regarding current trading prices, TGOD.TO is priced at $0.17, while CDVA.CN trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CDVA.CN's P/E ratio is -6.50. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CDVA.CN's ROE of +0.26%. Regarding short-term risk, TGOD.TO is more volatile compared to CDVA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs IMCC.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, IMCC.CN has a market cap of 7.00M. Regarding current trading prices, TGOD.TO is priced at $0.17, while IMCC.CN trades at $2.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas IMCC.CN's P/E ratio is -0.50. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to IMCC.CN's ROE of -1.52%. Regarding short-term risk, TGOD.TO is more volatile compared to IMCC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs MYCO.NE Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, MYCO.NE has a market cap of 6.33M. Regarding current trading prices, TGOD.TO is priced at $0.17, while MYCO.NE trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas MYCO.NE's P/E ratio is -0.22. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to MYCO.NE's ROE of +0.94%. Regarding short-term risk, TGOD.TO is more volatile compared to MYCO.NE. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs SNN.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, SNN.CN has a market cap of 6.08M. Regarding current trading prices, TGOD.TO is priced at $0.17, while SNN.CN trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas SNN.CN's P/E ratio is -0.15. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to SNN.CN's ROE of +0.00%. Regarding short-term risk, TGOD.TO is more volatile compared to SNN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs SE.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, SE.CN has a market cap of 5.81M. Regarding current trading prices, TGOD.TO is priced at $0.17, while SE.CN trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas SE.CN's P/E ratio is 2.14. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to SE.CN's ROE of -0.71%. Regarding short-term risk, TGOD.TO is more volatile compared to SE.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs FH.NE Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, FH.NE has a market cap of 5.24M. Regarding current trading prices, TGOD.TO is priced at $0.17, while FH.NE trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas FH.NE's P/E ratio is -1.00. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to FH.NE's ROE of -2.14%. Regarding short-term risk, TGOD.TO is more volatile compared to FH.NE. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs WLLW.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, WLLW.TO has a market cap of 5.07M. Regarding current trading prices, TGOD.TO is priced at $0.17, while WLLW.TO trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas WLLW.TO's P/E ratio is -0.70. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to WLLW.TO's ROE of -21.00%. Regarding short-term risk, TGOD.TO is more volatile compared to WLLW.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs BCBC.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, BCBC.CN has a market cap of 5.02M. Regarding current trading prices, TGOD.TO is priced at $0.17, while BCBC.CN trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas BCBC.CN's P/E ratio is -2.00. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to BCBC.CN's ROE of -4.27%. Regarding short-term risk, TGOD.TO and BCBC.CN have similar daily volatility (28.57).
TGOD.TO vs AYUR.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, AYUR.CN has a market cap of 4.87M. Regarding current trading prices, TGOD.TO is priced at $0.17, while AYUR.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas AYUR.CN's P/E ratio is -1.25. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to AYUR.CN's ROE of -3.52%. Regarding short-term risk, TGOD.TO is more volatile compared to AYUR.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs CANN.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CANN.CN has a market cap of 4.72M. Regarding current trading prices, TGOD.TO is priced at $0.17, while CANN.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CANN.CN's P/E ratio is -0.25. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CANN.CN's ROE of -0.66%. Regarding short-term risk, TGOD.TO is more volatile compared to CANN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs BHNG.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, BHNG.CN has a market cap of 4.70M. Regarding current trading prices, TGOD.TO is priced at $0.17, while BHNG.CN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas BHNG.CN's P/E ratio is -1.00. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to BHNG.CN's ROE of +4.01%. Regarding short-term risk, TGOD.TO is more volatile compared to BHNG.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs LOBE.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, LOBE.CN has a market cap of 4.58M. Regarding current trading prices, TGOD.TO is priced at $0.17, while LOBE.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas LOBE.CN's P/E ratio is -0.62. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to LOBE.CN's ROE of +1.67%. Regarding short-term risk, TGOD.TO is more volatile compared to LOBE.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs FFNT.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, FFNT.CN has a market cap of 4.57M. Regarding current trading prices, TGOD.TO is priced at $0.17, while FFNT.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas FFNT.CN's P/E ratio is -0.03. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to FFNT.CN's ROE of +0.79%. Regarding short-term risk, TGOD.TO is more volatile compared to FFNT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs LUFF.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, LUFF.CN has a market cap of 4.02M. Regarding current trading prices, TGOD.TO is priced at $0.17, while LUFF.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas LUFF.CN's P/E ratio is -0.56. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to LUFF.CN's ROE of -0.32%. Regarding short-term risk, Volatility data is not available for a full comparison. TGOD.TO has daily volatility of 28.57 and LUFF.CN has daily volatility of N/A.
TGOD.TO vs TILT.NE Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, TILT.NE has a market cap of 3.91M. Regarding current trading prices, TGOD.TO is priced at $0.17, while TILT.NE trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas TILT.NE's P/E ratio is -0.03. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to TILT.NE's ROE of -10.80%. Regarding short-term risk, TGOD.TO is less volatile compared to TILT.NE. This indicates potentially lower risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs BAMM.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, BAMM.CN has a market cap of 3.69M. Regarding current trading prices, TGOD.TO is priced at $0.17, while BAMM.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas BAMM.CN's P/E ratio is -0.12. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to BAMM.CN's ROE of +0.24%. Regarding short-term risk, TGOD.TO is more volatile compared to BAMM.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs RMC.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, RMC.CN has a market cap of 3.44M. Regarding current trading prices, TGOD.TO is priced at $0.17, while RMC.CN trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas RMC.CN's P/E ratio is -4.00. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to RMC.CN's ROE of +8.03%. Regarding short-term risk, TGOD.TO is more volatile compared to RMC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs THC.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, THC.CN has a market cap of 3.28M. Regarding current trading prices, TGOD.TO is priced at $0.17, while THC.CN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas THC.CN's P/E ratio is -1.00. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to THC.CN's ROE of +0.00%. Regarding short-term risk, TGOD.TO is more volatile compared to THC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs NBUD.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, NBUD.CN has a market cap of 3.17M. Regarding current trading prices, TGOD.TO is priced at $0.17, while NBUD.CN trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas NBUD.CN's P/E ratio is -1.25. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to NBUD.CN's ROE of -0.54%. Regarding short-term risk, TGOD.TO is more volatile compared to NBUD.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs XBRA.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, XBRA.CN has a market cap of 3.01M. Regarding current trading prices, TGOD.TO is priced at $0.17, while XBRA.CN trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas XBRA.CN's P/E ratio is -1.33. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to XBRA.CN's ROE of -20.92%. Regarding short-term risk, TGOD.TO is more volatile compared to XBRA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs MSVN.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, MSVN.CN has a market cap of 2.92M. Regarding current trading prices, TGOD.TO is priced at $0.17, while MSVN.CN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas MSVN.CN's P/E ratio is -0.06. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to MSVN.CN's ROE of +19.42%. Regarding short-term risk, TGOD.TO is more volatile compared to MSVN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs AREV.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, AREV.CN has a market cap of 2.86M. Regarding current trading prices, TGOD.TO is priced at $0.17, while AREV.CN trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas AREV.CN's P/E ratio is -2.25. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to AREV.CN's ROE of +2.76%. Regarding short-term risk, TGOD.TO is more volatile compared to AREV.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs ASP.TO Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, ASP.TO has a market cap of 2.77M. Regarding current trading prices, TGOD.TO is priced at $0.17, while ASP.TO trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas ASP.TO's P/E ratio is -0.08. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to ASP.TO's ROE of +3.10%. Regarding short-term risk, TGOD.TO is more volatile compared to ASP.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs CFT.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, CFT.CN has a market cap of 2.65M. Regarding current trading prices, TGOD.TO is priced at $0.17, while CFT.CN trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas CFT.CN's P/E ratio is -0.13. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to CFT.CN's ROE of +0.00%. Regarding short-term risk, TGOD.TO is more volatile compared to CFT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs IPOT.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, IPOT.CN has a market cap of 2.64M. Regarding current trading prices, TGOD.TO is priced at $0.17, while IPOT.CN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas IPOT.CN's P/E ratio is -0.50. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to IPOT.CN's ROE of +0.00%. Regarding short-term risk, TGOD.TO is more volatile compared to IPOT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs PBF.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, PBF.CN has a market cap of 2.61M. Regarding current trading prices, TGOD.TO is priced at $0.17, while PBF.CN trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas PBF.CN's P/E ratio is -0.37. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to PBF.CN's ROE of +1.52%. Regarding short-term risk, TGOD.TO is more volatile compared to PBF.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.
TGOD.TO vs TGIF.CN Comparison
TGOD.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGOD.TO stands at N/A. In comparison, TGIF.CN has a market cap of 2.45M. Regarding current trading prices, TGOD.TO is priced at $0.17, while TGIF.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGOD.TO currently has a P/E ratio of -0.74, whereas TGIF.CN's P/E ratio is -0.25. In terms of profitability, TGOD.TO's ROE is -0.90%, compared to TGIF.CN's ROE of +0.24%. Regarding short-term risk, TGOD.TO is more volatile compared to TGIF.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TGOD.TO.